Cellular and plasma proteomic determinants of COVID-19 and non-COVID-19 pulmonary diseases relative to healthy aging

Laura Arthur,Ekaterina Esaulova,Denis A. Mogilenko,Petr Tsurinov,Samantha Burdess,Anwesha Laha,Rachel Presti,Brian Goetz,Mark A. Watson,Charles W. Goss,Christina A. Gurnett,Philip A. Mudd,Courtney Beers,Jane A. O’Halloran,Maxim N. Artyomov
DOI: https://doi.org/10.1038/s43587-021-00067-x
2021-05-11
Nature Aging
Abstract:We examine the cellular and soluble determinants of coronavirus disease 2019 (COVID-19) relative to aging by performing mass cytometry in parallel with clinical blood testing and plasma proteomic profiling of ~4,700 proteins from 71 individuals with pulmonary disease and 148 healthy donors (25–80 years old). Distinct cell populations were associated with age (GZMK<sup>+</sup>CD8<sup>+</sup> T cells and CD25<sup>low</sup> CD4<sup>+</sup> T cells) and with COVID-19 (TBET<sup>−</sup>EOMES<sup>−</sup> CD4<sup>+</sup> T cells, HLA-DR<sup>+</sup>CD38<sup>+</sup> CD8<sup>+</sup> T cells and CD27<sup>+</sup>CD38<sup>+</sup> B cells). A unique population of TBET<sup>+</sup>EOMES<sup>+</sup> CD4<sup>+</sup> T cells was associated with individuals with COVID-19 who experienced moderate, rather than severe or lethal, disease. Disease severity correlated with blood creatinine and urea nitrogen levels. Proteomics revealed a major impact of age on the disease-associated plasma signatures and highlighted the divergent contribution of hepatocyte and muscle secretomes to COVID-19 plasma proteins. Aging plasma was enriched in matrisome proteins and heart/aorta smooth muscle cell-specific proteins. These findings reveal age-specific and disease-specific changes associated with COVID-19, and potential soluble mediators of the physiological impact of COVID-19.
What problem does this paper attempt to address?